WHITE PLAINS, N.Y.–Marsh McLennan Agency, a subsidiary of Marsh, today announced the acquisition of Arlington Heights, Illinois-based Trideo Systems, a risk management information system (RMIS) provider for health care organizations. Terms of the acquisition were not disclosed.
Founded in 2008, Trideo’s RMIS platform enables health care clients nationwide to efficiently manage risk from its inception as an adverse event, to its eventual resolution through the claims process, saving time through improved collaboration on its secured unified platform. All Trideo employees, including its Co-Founder and Senior Vice President Paresh Purohit, will join Marsh McLennan Agency and work out of the Schaumburg, Illinois office.
“Trideo’s commitment to high-quality client service and customized solutions strategically aligns with that of Marsh McLennan Agency,” commented Tony Chimino, CEO of Marsh McLennan Agency’s Midwest region. “With this acquisition, we will be able to leverage Trideo’s unique combination of technology and analytics capabilities in a new way for our clients in the health care industry, including health care systems and long-term care facilities.”
Mr. Purohit added: “The Trideo team is thrilled by this opportunity to join Marsh McLennan Agency and expand the reach of our solution. We look forward to seeing the impact of our software and data analytics as we implement it across health care industry clients to gain a deeper understanding of loss drivers, create new efficiencies and uncover opportunities to minimize risk.”
Source: Marsh McLennan Agency
AgencyEquity statement on this article:
Some of the statements in this third party article may be forward-looking statements and perhaps even inaccurate statements. AgencyEquity or Strategic Agencies LLC does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will AgencyEquity or Strategic Agencies LLC be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.
